UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparative lesion sequencing provides insights into tumor evolution

Proceedings of the National Academy of Sciences - PNAS, 2008-03, Vol.105 (11), p.4283-4288

2008

Volltextzugriff (PDF)

Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood

Clinical cancer research, 2012-06, Vol.18 (12), p.3462-3469

2012

Volltextzugriff (PDF)

BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions

Nature methods, 2006-07, Vol.3 (7), p.551-559

2006

Volltextzugriff (PDF)

Detection and Quantification of Mutations in the Plasma of Patients with Colorectal Tumors

Proceedings of the National Academy of Sciences - PNAS, 2005-11, Vol.102 (45), p.16368-16373

2005

Volltextzugriff (PDF)

Development of personalized tumor biomarkers using massively parallel sequencing

Science translational medicine, 2010-02, Vol.2 (20), p.20ra14

2010

Volltextzugriff (PDF)

BEAMing up for detection and quantification of rare sequence variants

Nature methods, 2006-02, Vol.3 (2), p.95-97

2006

Volltextzugriff (PDF)

Antibody microarrays: An evaluation of production parameters

Proteomics (Weinheim), 2003-03, Vol.3 (3), p.254-264

2003

Volltextzugriff (PDF)

Serial assessment of human tumor burdens in mice by the analysis of circulating DNA

Cancer research (Chicago, Ill.), 2007-10, Vol.67 (19), p.9364-9370

2007

Volltextzugriff (PDF)

Detection of Tumor DNA at the Margins of Colorectal Cancer Liver Metastasis

Clinical cancer research, 2011-06, Vol.17 (11), p.3551-3557

2011

Volltextzugriff (PDF)

Human Papillomavirus Type 16 E6 Promotes Retinoblastoma Protein Phosphorylation and Cell Cycle Progression

Journal of Virology, 2004-12, Vol.78 (24), p.13769-13778

2004

Volltextzugriff (PDF)

Sensitive digital quantification of DNA methylation in clinical samples

Nature biotechnology, 2009-09, Vol.27 (9), p.858-863

2009

Volltextzugriff (PDF)

Abstract 403: Performance assessment of highly sensitive NGS assay for TP53

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.403-403

2016

Volltextzugriff (PDF)

Abstract P041: Improved sensitivity of a multi-analyte early detection test based on mutation, methylation, aneuploidy, and protein biomarkers

Cancer prevention research (Philadelphia, Pa.), 2023-01, Vol.16 (1_Supplement), p.P041-P041

2023

Volltextzugriff (PDF)

Abstract IA023: Improved sensitivity of a multi-analyte early detection test based on mutation, methylation, aneuploidy, and protein biomarkers

Cancer prevention research (Philadelphia, Pa.), 2023-01, Vol.16 (1_Supplement), p.IA023-IA023

2023

Volltextzugriff (PDF)

Manufacturing DNA microarrays of high spot homogeneity and reduced background signal

Nucleic acids research, 2001-04, Vol.29 (7), p.E38-38

2001

Volltextzugriff (PDF)

Abstract 2449: Case report: DETECT-A participants with pre-malignant conditions

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.2449-2449

2024

Volltextzugriff (PDF)

Detection and Quantification of KIT Mutations in ctDNA by Plasma Safe-SeqS

Advances in experimental medicine and biology, 2016, Vol.924, p.187-189

2016

Volltextzugriff (PDF)

Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies

Oncotarget, 2015-05, Vol.6 (14), p.12809-12821

2015

Volltextzugriff (PDF)

Abstract 3145: Clinical evaluation of streck cell-free DNA blood collection tubes for liquid profiling in oncology

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3145-3145

2016

Volltextzugriff (PDF)

Abstract LB100: Performance of a multi-analyte, multi-cancer early detection (MCED) blood test in a prospectively-collected cohort

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.LB100-LB100

2024

Volltextzugriff (PDF)

Academia Meets Industry

Advances in experimental medicine and biology, 2016, Vol.924, p.201-215

2016

Volltextzugriff (PDF)

Abstract B42: RAS mutations detected by cell-free plasma DNA (BEAMing) assay may portend a favorable response to refametinib +/- sorafenib in hepatocellular carcinoma

Molecular cancer research, 2014-12, Vol.12 (12_Supplement), p.B42-B42

2014

Volltextzugriff (PDF)

Abstract B35: Acquired KRAS mutations after anti-EGFR therapy partially derive from low-frequency clones detectable in the primary tumor

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.B35-B35

2013

Volltextzugriff (PDF)

Heterogeneity of acquired KRAS and EGFR mutations in colorectal cancer patients treated with anti-EGFR monoclonal antibodies

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3512-3512

2013

Volltextzugriff (PDF)

Abstract B26: Actionable mutations in cell-free DNA in plasma of patients with advanced cancers referred for experimental targeted therapies

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.B26-B26

2013

Volltextzugriff (PDF)

1 – 25 von 288

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionSpringerLink

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(236)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(262)
Deutsch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(132)
Life Sciences & Biomedicine
(81)
Humans
(64)
Animals
(32)
Female
(30)
Technology
(29)
Biological And Medical Sciences
(26)
Physical Sciences
(24)
Male
(23)
Middle Aged
(21)
Medical Sciences
(20)
Mice
(20)
Aged
(16)
Biochemistry & Molecular Biology
(16)
Chemistry
(15)
Exact Sciences And Technology
(15)
Adult
(12)
Engineering
(12)
Science & Technology - Other Topics
(11)
Tumors
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Comparative lesion sequencing provides insights into tumor evolution

Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood

BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions

Detection and Quantification of Mutations in the Plasma of Patients with Colorectal Tumors

Development of personalized tumor biomarkers using massively parallel sequencing

BEAMing up for detection and quantification of rare sequence variants

Antibody microarrays: An evaluation of production parameters

Serial assessment of human tumor burdens in mice by the analysis of circulating DNA

Detection of Tumor DNA at the Margins of Colorectal Cancer Liver Metastasis

Human Papillomavirus Type 16 E6 Promotes Retinoblastoma Protein Phosphorylation and Cell Cycle Progression

Sensitive digital quantification of DNA methylation in clinical samples

Abstract 403: Performance assessment of highly sensitive NGS assay for TP53

Abstract P041: Improved sensitivity of a multi-analyte early detection test based on mutation, methylation, aneuploidy, and protein biomarkers

Abstract IA023: Improved sensitivity of a multi-analyte early detection test based on mutation, methylation, aneuploidy, and protein biomarkers

Manufacturing DNA microarrays of high spot homogeneity and reduced background signal

Abstract 2449: Case report: DETECT-A participants with pre-malignant conditions

Detection and Quantification of KIT Mutations in ctDNA by Plasma Safe-SeqS

Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies

Abstract 3145: Clinical evaluation of streck cell-free DNA blood collection tubes for liquid profiling in oncology

Abstract LB100: Performance of a multi-analyte, multi-cancer early detection (MCED) blood test in a prospectively-collected cohort

Academia Meets Industry

Abstract B42: RAS mutations detected by cell-free plasma DNA (BEAMing) assay may portend a favorable response to refametinib +/- sorafenib in hepatocellular carcinoma

Abstract B35: Acquired KRAS mutations after anti-EGFR therapy partially derive from low-frequency clones detectable in the primary tumor

Heterogeneity of acquired KRAS and EGFR mutations in colorectal cancer patients treated with anti-EGFR monoclonal antibodies

Abstract B26: Actionable mutations in cell-free DNA in plasma of patients with advanced cancers referred for experimental targeted therapies

Aktive Filter

Suchergebnisse filtern